Fertility and Sterility
Volume 76, Issue 3 , Pages 451-455 , September 2001

Effects of a short-term suspension of hormone replacement therapy on mammographic density

  • Nicola Colacurci, M.D.

      Affiliations

    • Outpatient Menopausal Clinic, Institute of Gynecology and Obstetrics, Naples, Italy
    • Corresponding Author InformationReprint requests: Nicola Colacurci, M.D., Via Manzoni 88, 80100 Naples, Italy (FAX: 39-81-459908 )
    • ,
  • Felice Fornaro, M.D.

      Affiliations

    • Outpatient Menopausal Clinic, Institute of Gynecology and Obstetrics, Naples, Italy
    • ,
  • Pasquale De Franciscis, M.D.

      Affiliations

    • Outpatient Menopausal Clinic, Institute of Gynecology and Obstetrics, Naples, Italy
    • ,
  • Daniela Mele, M.D.

      Affiliations

    • Outpatient Menopausal Clinic, Institute of Gynecology and Obstetrics, Naples, Italy
    • ,
  • Mario Palermo, M.D.

      Affiliations

    • Institute of Radiology, Second University of Naples, Naples, Italy
    • ,
  • Walter del Vecchio, M.D.

      Affiliations

    • Institute of Radiology, Second University of Naples, Naples, Italy

Received 29 December 2000 ,Revised 27 March 2001 ,Accepted 27 March 2001.

References 

  1. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol. 1977;4:31–47
  2. Stampfer MJ, Colditz GA, Willet WC, Manson JE, Rosner B, Speizar FE, et al.  Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med. 1991;325:756–762
  3. Ettinger B, Genant HK, Cann CE. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985;102:319–324
  4. Mattson LA. What do women want?. Br J Obstet Gynaecol. 1996;103:104–107
  5. Okon MA, Lee S, Li TC. A study to examine women’s knowledge, perception and acceptability of hormone replacement therapy. Eur Menopause J. 1996;3:47–52
  6. Collaborative Group on Hormonal Factors in Breast Cancer . Breast cancer and hormone replacement therapy (collaborative reanalysis of data from 51 epidemiological studies of 52705 women with breast cancer and 108411 women without breast cancer). Lancet. 1997;350:1047–1059
  7. Hurley SF, Kaldor JM. The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev. 1992;14:101–130
  8. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst. 1992;84:781–785
  9. van Gils CH, Otten JDM, Verbeek ALM, Hendriks JHCL, Holland R. Effect of mammographic breast density on breast cancer screening performance (a study in Nijmegen, the Netherlands). J Epidemiol Community Health. 1998;52:267–271
  10. Wolfe JN, Saftlas AF, Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities (a case-control study). Am J Roentgenol. 1987;148:1087–1092
  11. Berkowitz JE, Gatewood OMB, Goldblum LE, Gayler BW. Hormonal replacement therapy (mammographic manifestation). Radiology. 1990;174:199–201
  12. McNicholas MMJ, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP. Pain and increased mammographic density in women receiving hormone replacement therapy (a prospective study). Am J Roentgenol. 1994;163:311–315
  13. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormone replacement therapy on mammographic density and parenchymal pattern. Radiology. 1995;196:433–437
  14. Colacurci N, Mele D, De Franciscis P, Costa V, Fortunato N, De Seta L. Effects of tibolone on the breast. Eur J Obstet Gynecol Reprod Biol. 1998;80:235–238
  15. Laya MB, Larson EB, Taplin SH, White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst. 1996;88:643–649
  16. Litherland JC, Evans AJ, Wilson ARM. The effect of hormone replacement therapy on recall rate in the National Health Service Breast Screening Programme. Clin Radiol. 1997;52:276–279
  17. Cohen MEL. Effect of hormone replacement therapy on cancer detection by mammography. Lancet. 1997;349:1624
  18. Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet. 2000;355:270–274
  19. Black WC, Fletcher SW. Effects of estrogen on screening mammography (another complexity). J Natl Cancer Inst. 1996;88:627–628
  20. Harvey JA, Pinkerton JV, Herman CR. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity. J Natl Cancer Inst. 1997;89:1623–1625
  21. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol. 1997;15:3201–3207
  22. Marugg RC, van der Mooren MJ, Hendriks JH, Rolland R, Rujis S. Mammographic changes in postmenopausal women on hormone replacement therapy. Eur Radiol. 1997;7:749–755
  23. Lunsdröm E, Wilczek B, von Palffy Z, Söderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy (differences according to treatment). Am J Obstet Gynecol. 1999;181:348–352
  24. Özdemir A, Konus Ö, Nas T, Erbas G, Cosar S, Isik S. Mammographic and ultrasonographic study of changes in the breast related to HRT. Int J Gynecol Obstet. 1999;67:23–32
  25. Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA, Haslam SZ. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab. 1999;84:4559–4565
  26. Longacre TA, Bartow SA. A correlative morphologic study of the human breast and endothelium in the menstrual cycle. Am J Surg Pathol. 1986;10:382–393

PII: S0015-0282(01)01967-7

Fertility and Sterility
Volume 76, Issue 3 , Pages 451-455 , September 2001

Article Tools

* Image Usage & Resolution